Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials.
Br J Dermatol
; 187(6): 888-899, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-36082590
Full text:
1
Database:
MEDLINE
Main subject:
Respiratory Tract Infections
/
Skin Diseases, Infectious
/
Conjunctivitis
/
Dermatitis, Atopic
/
Kaposi Varicelliform Eruption
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
Language:
En
Year:
2022
Type:
Article